Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cerebrovascular endothelial dysfunction mediated by beta-amyloid

T Thomas1, C McLendon, E T Sutton

  • 1Woodlands Medical Center, Oldsmar, FL 34677, USA.

Neuroreport
|April 14, 1997
PubMed
Summary

Beta-amyloid (A beta) causes endothelial dysfunction in brain blood vessels, contributing to Alzheimer's disease (AD) pathology. Antioxidants like superoxide dismutase (SOD) can counteract these harmful effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physiological levels of beta-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production.

Neurological research·2001
Same author

Cell-free assays for gamma-secretase activity.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2000
Same author

Potassium channel openers prevent beta-amyloid toxicity in bovine vascular endothelial cells.

Neuroscience letters·2000
Same author

Animal model of Alzheimer-like vascular pathology and inflammatory reaction.

Annals of the New York Academy of Sciences·2000
Same author

Estrogen protects peripheral and cerebral blood vessels from toxicity of Alzheimer peptide amyloid-beta and inflammatory reaction.

Journal of submicroscopic cytology and pathology·2000
Same author

Pulmonary endothelial and epithelial integrity and neutrophil infiltration after endotoxin in interleukin-1 receptor knockout mice.

Shock (Augusta, Ga.)·2000

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Pathology

Background:

  • Beta-amyloid (A beta) toxicity is implicated in Alzheimer's disease (AD) pathology.
  • The precise role of A beta in neurodegeneration, particularly in the cerebrovascular system, remains unclear.
  • Previous research indicated A beta induces endothelial dysfunction in peripheral vessels via reactive oxygen species.

Purpose of the Study:

  • To investigate the direct impact of beta-amyloid (A beta) on cerebrovascular endothelial function.
  • To elucidate the mechanisms underlying A beta-induced endothelial damage in cerebral arteries.

Main Methods:

  • Treatment of bovine cerebral arteries with A beta 1-40.
  • Assessment of vascular reactivity to vasoconstrictors and vasodilators.

Related Experiment Videos

  • Electron microscopy to evaluate endothelial integrity.
  • Evaluation of antioxidant (superoxide dismutase and PBN) protective effects.

    • Main Results:

    • A beta 1-40 induced significant endothelial dysfunction in bovine cerebral arteries.
    • Observed effects included increased vasoconstriction and reduced vasodilation.
    • Electron microscopy confirmed substantial A beta-induced damage to the endothelium.
    • Superoxide dismutase (SOD) and PBN pretreatment successfully antagonized A beta's detrimental effects.

    Conclusions:

    • Beta-amyloid directly damages cerebrovascular endothelium, leading to dysfunction.
    • This endothelial damage may contribute to ischemic and inflammatory processes in Alzheimer's disease.
    • Antioxidant interventions show potential in mitigating A beta-induced vascular damage.